Always keep the vial in the refrigerator and limit the time it spends at room temperature
Glucagon-like peptide 1-receptor agonists and A1c: good for the heart but less so for the eyes
Compounded semaglutide, though available as an alternative during shortages, lacks FDA approval and standardized dosing, raising safety and effectiveness concerns
Common side effects: nausea, vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, and injection-site reactions
View Source THE LANCET Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes A Phase 2 Trial 2023 Rosenstock J, et al
Precise dosing and scheduling are fundamental to getting meaningful results when you combine tesamorelin and retatrutide